Snapshot 3: Connectathon 32 Base
MedicationsThis is Snapshot #3 for FHIR R5, released to support Connectathon 32. For a full list of available versions, see the Directory of published versions.
| Pharmacy Work Group | Maturity Level: N/A | Standards Status: Informative | Compartments: Encounter, Patient, Practitioner |
Raw JSON (canonical form + also see JSON Format Specification)
Request for Intravenous Chemotherapy (inpatient order) - Alemtuzumab - completed with multiple dosageInstruction lines
{
"resourceType" : "MedicationRequest",
"id" : "medrx0317",
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative: MedicationRequest</b><a name=\"medrx0317\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource MedicationRequest "medrx0317" </p></div><p><b>identifier</b>: id: 12345689 (use: OFFICIAL)</p><p><b>status</b>: completed</p><p><b>intent</b>: order</p><h3>Medications</h3><table class=\"grid\"><tr><td>-</td><td><b>Reference</b></td></tr><tr><td>*</td><td><a name=\"med0303\"> </a><blockquote><p/><p><a name=\"med0303\"> </a></p><p><b>code</b>: Alemtuzumab 10mg/ml (Lemtrada) <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://terminology.hl7.org/4.0.0/CodeSystem-v3-rxNorm.html\">RxNorm</a>#1594660)</span></p></blockquote></td></tr></table><p><b>subject</b>: <a href=\"patient-example-a.html\">Patient/pat1: Donald Duck</a> "Donald DUCK"</p><p><b>authoredOn</b>: 2015-01-15</p><p><b>requester</b>: <a href=\"practitioner-example-f007-sh.html\">Practitioner/f007: Patrick Pump</a> "Simone HEPS"</p><h3>Reasons</h3><table class=\"grid\"><tr><td>-</td><td><b>Concept</b></td></tr><tr><td>*</td><td>Chronic Lymphoid Leukemia (disorder) <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://browser.ihtsdotools.org/\">SNOMED CT</a>#92814006)</span></td></tr></table><blockquote><p><b>dose</b></p><blockquote><p><b>dosageInstruction</b></p><p><b>sequence</b>: 1</p><p><b>text</b>: Rapid daily-dose escalation, until tolerated, from 3 mg/d, and then 10 mg/d, to the recommended maintenance dose of 30 mg IV over 120 min, 3 times per wk on alternate days for up to 12 wk</p><p><b>additionalInstruction</b>: Rapidly increase dose until tolerated <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> ()</span>, Administer on alternate days <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> ()</span></p><p><b>timing</b>: Duration 12weeks, 3 per 1 weeks</p><p><b>route</b>: Intravenous route (qualifier value) <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://browser.ihtsdotools.org/\">SNOMED CT</a>#47625008)</span></p><p><b>method</b>: Inject - dosing instruction imperative (qualifier value) <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://browser.ihtsdotools.org/\">SNOMED CT</a>#422145002)</span></p></blockquote><blockquote><p><b>dosageInstruction</b></p><p><b>sequence</b>: 2</p><p><b>text</b>: Rapid daily-dose escalation, until tolerated, from 3 mg/d, and then 10 mg/d, to the recommended maintenance dose of 30 mg IV over 120 min, 3 times per wk on alternate days for up to 12 wk</p><p><b>additionalInstruction</b>: Rapidly increase dose until tolerated <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> ()</span>, Administer on alternate days <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> ()</span></p><p><b>timing</b>: Duration 12weeks, 3 per 1 weeks</p><p><b>route</b>: Intravenous route (qualifier value) <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://browser.ihtsdotools.org/\">SNOMED CT</a>#47625008)</span></p><p><b>method</b>: Inject - dosing instruction imperative (qualifier value) <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://browser.ihtsdotools.org/\">SNOMED CT</a>#422145002)</span></p></blockquote><blockquote><p><b>dosageInstruction</b></p><p><b>sequence</b>: 3</p><p><b>text</b>: Rapid daily-dose escalation, until tolerated, from 3 mg/d, and then 10 mg/d, to the recommended maintenance dose of 30 mg IV over 120 min, 3 times per wk on alternate days for up to 12 wk</p><p><b>additionalInstruction</b>: Rapidly increase dose until tolerated <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> ()</span>, Administer on alternate days <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> ()</span></p><p><b>timing</b>: Duration 12weeks, 3 per 1 weeks</p><p><b>route</b>: Intravenous route (qualifier value) <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://browser.ihtsdotools.org/\">SNOMED CT</a>#47625008)</span></p><p><b>method</b>: Inject - dosing instruction imperative (qualifier value) <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://browser.ihtsdotools.org/\">SNOMED CT</a>#422145002)</span></p></blockquote></blockquote></div>"
},
"contained" : [{
"resourceType" : "Medication",
"id" : "med0303",
"code" : {
"coding" : [{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"code" : "1594660",
"display" : "Alemtuzumab 10mg/ml (Lemtrada)"
}]
}
}],
"identifier" : [{
"use" : "official",
"system" : "http://www.bmc.nl/portal/prescriptions",
"value" : "12345689"
}],
"status" : "completed",
"intent" : "order",
"medication" : {
"reference" : {
"reference" : "#med0303"
}
},
"subject" : {
"reference" : "Patient/pat1",
"display" : "Donald Duck"
},
"authoredOn" : "2015-01-15",
"requester" : {
"reference" : "Practitioner/f007",
"display" : "Patrick Pump"
},
"reason" : [{
"concept" : {
"coding" : [{
"system" : "http://snomed.info/sct",
"code" : "92814006",
"display" : "Chronic Lymphoid Leukemia (disorder)"
}]
}
}],
"dose" : {
"dosageInstruction" : [{
"sequence" : 1,
"text" : "Rapid daily-dose escalation, until tolerated, from 3 mg/d, and then 10 mg/d, to the recommended maintenance dose of 30 mg IV over 120 min, 3 times per wk on alternate days for up to 12 wk",
"additionalInstruction" : [{
"text" : "Rapidly increase dose until tolerated"
},
{
"text" : "Administer on alternate days"
}],
"timing" : {
"repeat" : {
"duration" : 12,
"durationUnit" : "wk",
"frequency" : 3,
"period" : 1,
"periodUnit" : "wk"
}
},
"route" : {
"coding" : [{
"system" : "http://snomed.info/sct",
"code" : "47625008",
"display" : "Intravenous route (qualifier value)"
}]
},
"method" : {
"coding" : [{
"system" : "http://snomed.info/sct",
"code" : "422145002",
"display" : "Inject - dosing instruction imperative (qualifier value)"
}]
},
"doseAndRate" : [{
"type" : {
"coding" : [{
"system" : "http://terminology.hl7.org/CodeSystem/dose-rate-type",
"code" : "ordered",
"display" : "Ordered"
}]
},
"doseQuantity" : {
"value" : 3,
"unit" : "mg",
"system" : "http://unitsofmeasure.org",
"code" : "mg"
}
}]
},
{
"sequence" : 2,
"text" : "Rapid daily-dose escalation, until tolerated, from 3 mg/d, and then 10 mg/d, to the recommended maintenance dose of 30 mg IV over 120 min, 3 times per wk on alternate days for up to 12 wk",
"additionalInstruction" : [{
"text" : "Rapidly increase dose until tolerated"
},
{
"text" : "Administer on alternate days"
}],
"timing" : {
"repeat" : {
"duration" : 12,
"durationUnit" : "wk",
"frequency" : 3,
"period" : 1,
"periodUnit" : "wk"
}
},
"route" : {
"coding" : [{
"system" : "http://snomed.info/sct",
"code" : "47625008",
"display" : "Intravenous route (qualifier value)"
}]
},
"method" : {
"coding" : [{
"system" : "http://snomed.info/sct",
"code" : "422145002",
"display" : "Inject - dosing instruction imperative (qualifier value)"
}]
},
"doseAndRate" : [{
"type" : {
"coding" : [{
"system" : "http://terminology.hl7.org/CodeSystem/dose-rate-type",
"code" : "ordered",
"display" : "Ordered"
}]
},
"doseQuantity" : {
"value" : 10,
"unit" : "mg",
"system" : "http://unitsofmeasure.org",
"code" : "mg"
}
}]
},
{
"sequence" : 3,
"text" : "Rapid daily-dose escalation, until tolerated, from 3 mg/d, and then 10 mg/d, to the recommended maintenance dose of 30 mg IV over 120 min, 3 times per wk on alternate days for up to 12 wk",
"additionalInstruction" : [{
"text" : "Rapidly increase dose until tolerated"
},
{
"text" : "Administer on alternate days"
}],
"timing" : {
"repeat" : {
"duration" : 12,
"durationUnit" : "wk",
"frequency" : 3,
"period" : 1,
"periodUnit" : "wk"
}
},
"route" : {
"coding" : [{
"system" : "http://snomed.info/sct",
"code" : "47625008",
"display" : "Intravenous route (qualifier value)"
}]
},
"method" : {
"coding" : [{
"system" : "http://snomed.info/sct",
"code" : "422145002",
"display" : "Inject - dosing instruction imperative (qualifier value)"
}]
},
"doseAndRate" : [{
"type" : {
"coding" : [{
"system" : "http://terminology.hl7.org/CodeSystem/dose-rate-type",
"code" : "ordered",
"display" : "Ordered"
}]
},
"doseQuantity" : {
"value" : 30,
"unit" : "mg",
"system" : "http://unitsofmeasure.org",
"code" : "mg"
}
}]
}]
}
}
Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.
FHIR ®© HL7.org 2011+. FHIR R5 Ballot hl7.fhir.core#5.0.0-snapshot3 generated on Wed, Dec 14, 2022 07:16+1100.
Links: Search |
Version History |
Contents |
Glossary |
QA |
Compare to R4B |
Compare to R5 Draft |
|
Propose a change